Barlogie et al established the classic regimen of melphalan plus prednisone (MP) in a randomized trial of 183 patients with myeloma in which ... survival, the spinal lesions incurred during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback